ULUSLARARASI KİTAP ULUSLARARASI YAYINLARULUSLARARASI BİLDİRİLER

ULUSLARARASI KİTAP


1.    Dementia with Leyw Bodies and Parkinson’s Disease Dementia “Oxford Textbook of Cognitive Neurology and Dementia” H.A. Hanağası, B. Bilgiç, M. Emre.  (Edited Masud Husain, Jonathan M. Schott). Oxford University Press, United Kingdom, 399-412, 2016.

2.    Parkinson’s Diseaese and Movement Disorders “Dementia Associated with Parkinson’s Disease: Features and Management”. H.A. Hanağası, M. Emre (Editors Joseph Jankovic, Eduardo Tolosa). Wolters Kluwer 125-137, 2015.

3.    Neuropsychiatric Symptoms of Movement Disorders. “Parkinson’s Disease Dementia”. Bilgiç, H.A. Hanağası, M. Emre (Edited by H. Reichmann) Switzerland, Springer 53-78, 2015.

4.    You’re listening to a sample of the Audible audio edition.  Dementia: Comprehensive Principles and Practices.”Dementia with Lewy Bodies and Parkinson’s Disease Dementia” H.A. Hanağası, B. Bilgiç, M. Emre (Edited by Bradford Dickerson, Alireza Atri). Oxford University Press New York, 231-259, 2014.

5.    Neuropsychiatric and Cognitive Changes in Parkinson’s Disease and Related Movement Disorders. “Parkinson’s Disease Dementia”. B. Bilgiç, H.A. Hanağası, M. Emre (Edited by Dag Aarsland, Jeffrey Cummings, Daniel Weintraub, K. Ray Chaudhuri). Cambridge University Press London, 177-191 2013.

6.    Movement Disorders: Unforgettable Cases and Lessons from the Bedside. “ABC of ataxia should also include E”. H.A. Hanağası, M. Emre (Editors H.  H. Fernandez, J. Marcelo). Demos Medical Publishing, New York, 238-239, 2013.

7.    Movement Disorders “Parkinson Disease Dementia”, M. Emre,  H.A. Hanağası,  David J. Burn (Editors RL. Watts, D. Standart, JA. Obeso). Mc Graw Hill, New York, 361-375, 2011.

8.    Movement Disorders 100 Instructive Cases. Chapter: 26 “When both motion and mentation fail”. H.A. Hanağası, M. Emre (Edited by Stephen Reich). Informa UK Ltd, London, 107-110, 2008.


ULUSLARARASI YAYINLAR

1.     An assessment of Movement Disorder Society Task Force Diagnostic Criteria for Mild Cognitive Impairment in Parkinson’s Disease. Uysal-Cantürk, HA. Hanağası, B. Bilgiç, H. Gürvit, M. Emre. Eur J Neurol. 2017 Sep 20. doi: 10.1111/ene.13467.

2.    Mutations in TYROBP are not a common cause of dementia in a Turkish cohort. Darwent, S. Carmona, E. Lohmann, G. Guven, C. Kun-Rodrigues, B. Bilgiç, HA. Hanağası, H. Gurvit, N. Erginel-Unaltuna, M. Pak, J. Hardy, A. Singleton, J. BrásJ, R. Guerreiro. Neurobiol Aging. 2017 Jun 28. pii: S0197-4580(17)30215-4.

3.    SYNE1 related cerebellar ataxia presents with variable phenotypes in a consanguineous family from Turkey. Yucesan, SA. Ugur Iseri, B. Bilgiç, Z. Gormez, B. Bakir Gungor, A. Sarac, O. Ozdemir, M. Sagiroglu, H. Gürvit, HA. Hanağası, U. Ozbek. Neurol Sci. 2017 Jul 7. doi: 10.1007/s10072-017-3049-8. [Epub ahead of print]

4.    The p.Thr11Met mutation in c19orf12 is frequent among adult Turkish patients with MPAN. Olgiati, O. Doğu, Z. Tufekcioglu, Y. Diler, E. Saka, M. Gultekin, H. Kaleagasi, D. Kuipers, J. Graafland, GJ. Breedveld, M. Quadri, R. Sürmeli, G. Sünter, T. Doğan, AD. Yalçın, B. Bilgiç, B. Elibol, M. Emre, HA. Hanağası, V. Bonifati. Parkinsonism Relat Disord. 2017 Mar 21. pii: S1353-8020(17)30107-4.

5.    Dementia in Parkinson’s disease. Hanağası, Z. Tüfekçioglu, M. Emre. J Neurol Sci. 2017 Jan 5. pii: S0022-510X(17)30014-X. doi: 10.1016/j.jns.2017.01.012.

6.    Clinical and genetic features of PKAN patients in a tertiary centre in Turkey. Akcakaya, SU. Iseri, B. Bilir, E. Battaloglu, P. Tekturk, M. Gultekin, G. Akar. R. Yigiter, HA. Hanağası, R. Alp, S. Cagirici, M. Eraksoy, U. Ozbek, Z. Yapici. Clin Neurol Neurosurg. 2017 Jan 15;154:34-42.

7.    Cognitive and anatomical correlates of anosognosia in amnestic mild cognitive impairment and early-stage Alzheimer’s disease. Senturk, B. Bilgic, AB. Arslan, A. Bayram, HA. Hanağası, H. Gurvit, M. Emre. Int Psychogeriatr. 2017;29(2):293-302.

8.    Analysis of the tremor in juvenile myoclonic epilepsy. Aydin-Özemir, Z. Matur, B. Baykan, B. Bilgic, P. Tekturk, N. Bebek, C. Gurses, HA. Hanağası, AE. Oge. Epilepsy Res. 2016 Oct 26;128:140-148.

9.    Analysis of Mutations in AARS2 in a Series of CSF1R-Negative Patients With Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia. Lynch, WJ. Zhang, R. Lakshmanan, JA. Kinsella, GA. Uzun, M. Karbay, Z. Tüfekçioglu, HA. Hanağası, G. Burke, N. Foulds, SR. Hammans, A. Bhattacharjee, H. Wilson, M. Adams, M. Walker, JA. Nicoll, J. Chataway, N. Fox, I. Davagnanam, R. Phadke, H. Houlden. JAMA Neurol. 2016;73(12):1433-1439.

10.   Mutation Frequency of the Major Frontotemporal Dementia Genes, MAPT, GRN and C9ORF72 in a Turkish Cohort of Dementia Patients. Guven G, E. Lohmann, J. Bras, JR. Gibbs, H. Gurvit, B. Bilgic, HA. Hanağası, P. Rizzu, P. Heutink, M. Emre, N. Erginel-UnaltunaW. Just, J. Hardy, A. Singleton, R. Guerreiro. PLoS One.2016 Sep 15;11(9):e0162592.

11.   Vitamin D deficiency might pose a greater risk for ApoEɛ4 non-carrier Alzheimer’s disease patients. Dursun, M. Alaylıoğlu, B. Bilgiç, HA. Hanağası, E. Lohmann, IL. Atasoy, E. Candaş, ÖS. Araz, B. Önal, H. Gürvit, S. Yılmazer, D. Gezen-Ak. Neurol Sci. 2016 Oct;37(10):1633-43.

12.   GC and VDR SNPs and Vitamin D Levels in Parkinson’s Disease: The Relevance to Clinical Features. Gezen-Ak, M. Alaylıoğlu, G. Genç, A. Gündüz, E. Candaş, B. Bilgiç, İL. Atasoy, H. Apaydın, G. Kızıltan, H. Gürvit, HA. Hanağası, S. Ertan, S. Yılmazer, E. Dursun. Neuromolecular Med. 2016 Jun 9. [Epub ahead of print]

13.   PLA2G6 Mutations Related to Distinct Phenotypes: A New Case with Early-onset Parkinsonism. Giri, G Güven, HA. Hanagasi, AK. Hauser, N. Erginul-Unaltuna, B. Bilgiç, H. Gürvit, P. Heutink, T. Gasser, E. Lohmann, J. Simón-Sánchez. Tremor Other Hyperkinet Mov (N Y). 2016 Mar 16;6:363. doi: 10.7916/D81G0M12.

14.   The Association Between Clusterin and APOE Polymorphisms and Late-Onset Alzheimer Disease in a Turkish Cohort. Alaylıoğlu, D. Gezen-Ak, E. Dursun, B. Bilgiç, HA. Hanagasi, T. Ertan, H. Gürvit, M. Emre, E. Eker, Ö. Uysal, S. Yılmazer. J Geriatr Psychiatry Neurol. 2016 29:221-6.

15.   A novel homozygous DJ1 mutation causes parkinsonism and ALS in a Turkish family. Hanagasi, A. Giri, G. Guven, B. Bilgiç, AK. Hauser, M. Emre, P. Heutink, N. Basak, T. Gasser, J. Simon-Sanchez, E. Lohmann. Parkinsonism and Related Disorders 2016; 29:117-20.

16.   Adult-onset phenylketonuria with rapidly progressive dementia and parkinsonism. Tufekcioglu, A. Cakar, B. Bilgic, HA. Hanagasi, H. Gurvit, M. Emre. Neurocase. 2016;22(3):273-5.

17.   Expression changes of genes associated with apoptosis and survival processes in Parkinson’s disease. Yalçınkaya, H. Haytural, B. Bilgiç, Ö. Özdemir, HA. Hanağası, Cİ. Küçükali, Z. Özbek, U. Akcan, HA. İdrisoğlu, H. Gürvit, E. Tüzün. Neurosci Lett. 2016 Feb 26;615:72-7.

18.   NMDA Receptor Encephalitis with Cancer of Unknown Primary Origin. A. Çoban, G Gündoğdu, M. Poyraz, G. Yegen, A. Demirtaş-Tatlıdede, B. Bilgiç, HA. Hanagasi, E. Tüzün, H. Gürvit. Tumori. 2015 Oct 20;0(0):0. doi: 10.5301/tj.5000447.

19.   A new F-box protein 7 gene mutation causing typical Parkinson’s disease. Lohmann, AS. Coquel, A. Honoré, H. Gurvit, HA. Hanağası, M. Emre, AL. Leutenegger, V. Drouet, M. Sahbatou, G. Guven, N. Erginel-Unaltuna, JF. Deleuze, S. Lesage, A. Brice. Mov Disord. 2015 30(8):1130-3.

20.   The interleukin 1 alpha, interleukin 1 beta, interleukin 6 and alpha-2-macroglobulin serum levels in patients with early or late onset Alzheimer’s disease, mild cognitive impairment or Parkinson’s disease. Dursun, D. Gezen-Ak, HA. Hanağası, B. Bilgiç, E. Lohmann, S. Ertan, İL.Atasoy, M. Alaylıoğlu, ÖS. Araz, B. Önal, A. Gündüz, H. Apaydın, G. Kızıltan, T. Ulutin, H. Gürvit, Yılmazer S. J Neuroimmunol. 2015 Jun 15;283:50-7.

21.   Clinical variability in ataxia-telangiectasia. E. Lohmann, S. Krüger, AK. Hauser, Hanağası, G. Guven, N. Erginel-Unaltuna, S. Biskup, T. Gasser. J Neurol. 2015;262(7):1724-7.

22.   Secondary paroxysmal kinesigenic dyskinesia associated with CLCN2 gene mutation. Hanağası, B. Bilgiç, TE. Abbink, F. Hanagasi, Z. Tüfekçioğlu, H. Gürvit, N. Başak, MS. van der Knaap, M. Emre. Parkinsonism Relat Disord. 2015;5:544-546.

23.   The distinct genetic pattern of ALS in Turkey and novel mutations. Özoğuz, Ö. Uyan, G. Birdal, C. Iskender, E. Kartal, S. Lahut, Ö. Ömür, ZS. Agim, AG. Eken, NE. Sen, P. Kavak, C. Saygı, PC. Sapp, P. Keagle, Y. Parman, E. Tan, F. Koç, F. Deymeer, P. Oflazer P, HA. Hanağası, H. Gürvit, B. Bilgiç, H. Durmuş, M. Ertaş, D. Kotan, MA. Akalın, H. Güllüoğlu, M. Zarifoğlu, F. Aysal, N. Döşoğlu, K. Bilguvar, M. Günel, Ö. Keskin, T. Akgün, H. Özçelik, JE. Landers, RH. Brown, AN. Başak. Neurobiol Aging. 2015 2015 Apr;36(4):1764.e9-1764.e18.

24.   Prevalence of Parkinson’s disease in Baskale, Turkey: a population based study. Durmuş, MA. Gökalp, HA. Hanağası. Neurol Sci. 2015;36(3):411-3.

25.  FBXO7-R498X mutation: Phenotypic variability from chorea to early onset parkinsonism within a family. Gündüz, AG. Eken,B. Bilgiç, HA. Hanagasi, K. Bilgüvar, M. Günel, AN. Başak, S. Ertan. Parkinsonism Relat Disord. 2014:1253-1256.

26.   Evaluation of Incidence and Clinical Features of Antibody-Associated Autoimmune Encephalitis Mimicking Dementia. A.Çoban, Cİ. Küçükali, B. Bilgiç, N. Yalçınkaya, H. Haytural, C. Ulusoy, S. Turan, S. Çakır, A. Üçok, H. Ünübol, HA. Hanağası, H. Gürvit, E. Tüzün. Behavioural Neurology   2014 (2014), Article ID 935379.

27.   Orolingual dyskinesia and involuntary neck movements caused by phenytoin intoxication. Gunduz, E. Kocasoy-Orhan, HA. Hanağası. J Neuropsychiatry Clin Neurosci. 2013 Oct 1;25(4):E51.

28.   Neuroimaging, Biomarkers, and Management of Dementia with Lewy Bodies. Hanağası, B. Bilgiç, M. Emre. Front Neurol. 2013 Oct 7;4:151

29.   BDNF, TNFα, HSP90, CFH, and IL-10 Serum Levels in Patients with Early or Late Onset Alzheimer’s Disease or Mild Cognitive Impairment. Gezen-Ak, E. Dursun, HA. Hanağası, B. Bilgiç, E. Lohman, OS. Arz, I. Atasoy, M. Alaylıoğlu, B. Onal, H. Gürvit,, S. Yilmazer. J Alzheimers Dis. 2013;37(1):185-95.

30.   A novel compound heterozygous mutation in TREM2 found in a Turkish frontotemporal dementia-like family. Guerreiro, B. Bilgic, G. Guven, J. Brás, J. Rohrer, E. Lohmann, HA. Hanağası, H. Gurvit, M. Emre. Neurobiol Aging. 2013 34(12):2890.

31.   Non-Convulsive Status Epilepticus Associated With Glutamic Acid Decarboxylase Antibody. Çikrikçili, C. Ulusoy, S. Turan, S. Yildiz, B. Bilgiç, HA. Hanağası, B. Baykan, E. Tüzün, H. Gürvit. Clin EEG Neurosci 2013 44: 232-236.

32.   Reduced Orexin-A Levels in Frontotemporal Dementia: Possible Association With Sleep Disturbance. Coban, B. Bilgiç, E. Lohmann, CI Küçükali, G. Benbir, D. Karadeniz, HA. Hanağası, E. Tüzün, H. Gurvit. Am J Alzheimers Dis Other Demen. 2013;28(6):606-11.

33.   Silent neurological involvement in biopsy-defined coeliac patients. Bilgiç, D. Aygun, AB.Arslan, A. Bayram, F. Akyuz,  S. Sencer, HA. Hanağası. Neurol Sci 2013: 34(12):2199-204

34.   A rare dementing disease: adult neuronal ceroid lipofuscinoses. Babacan-Yildiz, HA. Hanağası, H. Gurvit, G. Şirin, S. Solakoglu, OS Kucuk. J Neuropsychiatry Clin Neurosci. 2012;24(4):493-8.

35.   Pure gait disturbance displayed by malingerers: Case report of two patients. Benbir, F. Hanağası, S. Ertan, HA. Hanağası, T. Ertan. Clin Neurol Neurosurg. 2013 Jul;115(7):1177-9.

36.   Using Exome Sequencing to Reveal Mutations in TREM2 Presenting as a Frontotemporal Dementia-like Syndrome Without Bone Involvement. Guerreiro, E. Lohmann, JM. Brás, JR. Gibbs, JD. Rohrer, N. Gurunlian, B. Dursun, B. Bilgic, HA. Hanağası, H. Gurvit, M. Emre, A. Singleton, J. Hardy. JAMA Neurol.  2013;70:78-84.

37.   Vitamin d receptor gene haplotype is associated with late-onset Alzheimer’s disease. Gezen-Ak, E. Dursun, B. Bilgiç, HA. Hanağası, T. Ertan, H. Gürvit, M. Emre, E. Eker, T. Ulutin, O. Uysal, S. Yilmazer. Tohoku J Exp Med. 2012;228(3):189-96.

38.   Dementia and behavioral neurology: recent advances. Bilgic B, HA. Hanağası, M. Emre. J Neurol. 2012;259:1006-10.

39.   Identification of PSEN1 and PSEN2 gene mutations and variants in Turkish dementia patients. Lohmann, RJ. Guerreiro, N. Erginel-Unaltuna, N. Gurunlian, B. Bilgic, H. Gurvit, HA. Hanağası, N. Luu, M. Emre, A. Singleton. Neurobiol Aging. 2012; 33:1850.e17-27.

40.   Differentiating symptomatic Parkin mutations carriers from patients with idiopathic Parkinson’s disease: Contribution of automated segmentation neuroimaging method. B. Bilgiç, A.Bayram, AB Arslan, HA. Hanağası, B. Dursun, H. Gurvit, M. Emre, E. Lohmann. Parkinsonism Relat Disord. 2012;18:562-6.

41.   Exome sequencing reveals an unexpected genetic cause of disease: NOTCH3 mutation in a Turkish family with Alzheimer’s disease. Guerreiro, E. Lohmann, E. Kinsella, JM. Brás, N. Luu, N. Gurunlian, B. Dursun, B. Bilgic, I. Santana, HA. Hanağası, H. Gurvit, JR. Gibbs, C. Oliveira, M. Emre, A. Singleton. Neurobiology of Aging 2012 May;33(5):1008.e17-23.

42.   Genetic bases and phenotypes of autosomal recessive Parkinson disease in a Turkish population. Lohmann, B. Dursun, S. Lesage, HA. Hanağası, G. Kayacı, A. Honoré, B. Bilgiç, O. Dogu, H. Kaleagasi, G. Babacan, J. , H. Gürvit, N. Erginel-Unaltuna, A. Brice, M Emre. Eur J Neurol. 2012 May;19(5):769-775.

43.   A homozygous frameshift mutation of sepiapterin reductase gene causing parkinsonism with onset in childhood. Lohmann, C. Köroğlu, HA. Hanağası, B. Dursun, E. Taşan E, A. Tolun. Parkinsonism Relat Disord. 2012 ;18:191-3.

44.   The Impact of Familial Structure on Parkinson’s Disease in Istanbul Medical School, Turkey. Lohmann, HA. Hanağası, H. Gürvit, G. Kayacı, M. Ruberg, J. Yazıcı, M. Emre. Int J Neurosci. 2012;122:102-5.

45.   LRRK2 mutations are uncommon in Turkey. Hanağası, E. Lohmann, B. Dursun, A. Honoré, S. Lesage, O. Dogu, H. Kaleagasi, O. Aydın, H. Gürvit, N. Erginel-Unaltuna, A. Brice, M Emre. Eur J Neurol. 2011;18(10):137.

46.   Erdheim Chester disease presenting as slowly progressive cerebellar syndrome and asymptomatic widespread skeletal involvement. Tufan, B. Myftiu, D. Aygun, N. Keles, J. Haroche, HA. Hanağası, H. Gurvit, M. Emre, S. Besisik. Eur J Neurol. 2011;18(8):93.

47.   The effects of rasagiline on cognitive deficits in Parkinson’s disease patients without dementia: A randomized, double-blind, placebo-controlled, multi-center study. Hanağası, H. Gurvit, P. Unsalan, H. Horozoglu, N. Tuncer, A. Feyzioglu, DI. Gunal, GG. Yener, R. Cakmur, HA. Sahin, M. Emre. Mov Disord. 2011; 26: 1851–1858.

48.   Pain is common in Parkinson’s disease. Hanağası, S. Akat, H. Gurvit, J. Yazici, M. Emre. Clinical Neurology and Neurosurgery 2011;113:11-3.

49.   Early-Onset L-dopa-Responsive Parkinsonism withPyramidal Signs Due to ATP13A2, PLA2G6, FBXO7 and Spatacsin Mutations. Paisán-Ruiz, R. Guevara, M. Federoff, HA. Hanağası,F. Sina, E. Elahi, SA. Schneider, P. Schwingenschuh, N. Bajaj, M. Emre, AB. Singleton, J. Hardy, KP. Bhatia, S. Brandner, AJ. Lees, H. Houlden. Mov Disord. 2010; 25:1791-1800.

50.   An unusual late presentation of subacute sclerosing panencephalitis with psychotic symptoms. Baran, HA. Hanağası,A. Uçok. J Neuropsychiatry Clin Neurosci. 2010;22(1):123.

51.   Iatrogenic Botulism After Botulinum Toxin Type A Injections. Çoban A, Z. Matur, HA. Hanağası,Y. Parman. Clin Neuropharmacol. 2010 May;33(3):158-60.

52.   Mitochondrial pathology in muscle of a patient with a novel parkin mutation. Hanağası, P. Serdaroglu, M. Ozansoy, N. Basak,  Hatice Tasli, M. Emre. International Journal of Neuroscience, 2009;119:1572 – 1583.

53.   The combinations of TNFalpha-308 and IL-6 -174 or IL-10 -1082 genes polymorphisms suggest an association with susceptibility to sporadic late-onset Alzheimer’s disease. Vural, S. Değirmencioğlu, H. Parıldar-Karpuzoğlu, S. Doğru-Abbasoğlu, HA. Hanağası, B. Karadağ, H Gürvit, M. Emre, M. Uysal. Acta Neurol Scand. 2009;120:396-401.

54.   Comparison of unilateral pallidotomy and subthalamotomy findings in advanced idiopathic Parkinson’s disease. Çoban, HA. Hanağası, S. Karamürsel, O. Barlas. Br J Neurosurg. 2009;23:23-9.

55.   Single nucleotide polymorphisms in base-excision repair genes hOGG1, APE1 and XRCC1 do not alter risk of Alzheimer’s disease. Parıldar-Karpuzoğlu, S. Doğru-Abbasoğlu, HA. Hanağası, B. Karadağ, H.Gürvit, M. Emre, M. Uysal. Neurosci Lett. 2008;442:287-91.

56.   The prevalence of dementia in an urban Turkish population. Gurvit, M. Emre, S. Tinaz, B. Bilgic, HA. Hanağası, H. Sahin, E. Gurol, JT. Kvaloy, H. Harmanci. Am J Alzheimers Dis Other Demen. 2008;23:67-76.

57.   Presenilin-1 Gene Intronic Polymorphism and Late-onset Alzheimer’s Disease. Dursun, D. Gezen-Ak, T. Ertan, HA. Hanağası, H. Gürvit, M. Emre, E. Eker, M. Oztürk, F. Engin, S. Yilmazer. Journal of Geriatric Psychiatry and Neurology 2008;21:268-73.

58.   Subclinical Impairment of Neuromuscular Transmission in Transient Global Amnesia. Ertas, H. Bolay, E. Kocasoy-Orhan, HA. Hanağası , B. Baykan. Cogn Behav Neurol. 2007;20:179-183.

59.   Association between Vitamin D Receptor Gene Polymorphism and Alzheimer’s Disease. Gezen-Ak D, E. Dursun E, T. Ertan T, HA. Hanağası, H. Gürvit, M. Emre, E. Eker, M. Oztürk, F. Engin, S. Yilmazer. Tohoku J Exp Med. 2007;212:275-82.

60.   Clinical and magnetic resonance imaging findings of HIV-Negative patients with neurosyphilis. Gurses, B. Bilgic, B. Topcular, OG. Tuncer, G. Akman-Demir, HA. Hanağası, B. Baslo, H. Gurvit, O. Coban, M. Emre, HA. Idrisoglu. J Neurol. 2007;254:368-374.

61.   The Arg194Trp polymorphism in DNA repair gene XRCC1 and the risk for sporadic late-onset Alzheimer’s disease. S. Dogru-Abbasoğlu, G. Aykaç-Toker, HA. Hanağası, H. Gürvit, M. Emre. M. Uysal. Neurol Sci 2007;28:31-4.

62.   Neurosyphilis presenting with status epilepticus.C. Gurses, M. Kurtuncu, J. Jirsch, N. Yesilot, HA. Hanagasi, N. Bebek, B. Baykan, M. Emre, A. Gokyigit, F. Andermann. Epileptic Disord. 2007;9:51-56.

63.   Smoking-responsive juvenile-onset Parkinsonism. Hanagasi, A. Lees, JO. Johnson, A. Singleton, M. Emre. Movement Disorders 2007;1:115-119.

64.   Polymorphisms in the DNA repair genes XPD (ERCC2) and XPF (ERCC4) are not associated with sporadic late-onset Alzheimer’s disease. S. Dogru-Abbasoğlu, M. İnceoğlu, H. Parıldar-Karpuzoğlu, HA. Hanağası, B. Karadağ, H. Gürvit, M. Emre. G. Aykaç-Toker, M. Uysal. Neuroscience Letters 2006;404:258-61.

65.   The apolipoprotein E (APOE)  genotype in a Turkish population with Alzheimer’s disease. Yokeş, M. Emre, H. Harmancı, H. Gürvit, HA. Hanağası, H. Şahin, B. Bilgiç, AN. Başak. Balkan Journal of Medical Genetics 2005;8:57-63.

66.   The attitude of elderly lay people towards the symptoms of dementia. Sahin, IH. Gurvit, M. Emre, HA. Hanağası , B. Bilgic, H. Harmancı. International Psychogeriatrics 2006; 18:251-258.

67.   What is the cause of this woman’s symptoms? Hanağası, M. Emre. Practical Neurology 2005;5:187-188.

68.  Destructive stereotactic surgery for treatment of dystonia. İmer, B. Özeren, S. Karadereler, Z. Yapıcı, B. Omay, HA. Hanağası, M. Eraksoy. Surg Neurol. 2005;64 (Suppl 2):89-94.

69.   Parkin expression in human skeletal muscle. Serdaroğlu, H. Taşlı, HA. Hanağası, M. Emre. J Clin Neurosci. 2005;12:928-30.

70.   Parkin expression in muscle from three patients with autosomal recessive Parkinson’s disease carrying parkin mutation. Serdaroğlu, HA. Hanağası, H. Taşlı, M. Emre. Acta Myologica 2005;24:2-5.

71.   Treatment of behavioural symptoms and dementia in Parkinson’s disease. Hanağası, M. Emre. Fundamental and Clinical Neuropharmacology 2005;19:133-146.

72.   Mitochondrial complex I, II/III and IV activities in familial and sporadic Parkinson’s disease. Hanağası, D. Ayribaş, K. Baysal, M. Emre. International Journal of Neuroscience 2005;115:479-493.

73.   PARK11 is not linked with Parkinson’s disease in European families. Prestel, M. Sharma, P. Leitner, A. Zimprich, JR. Vaughan, A. Dürr, V. Bonifati, G. De Michele, HA. Hanağası, M. Farrer, A. Hofer, F. Asmus, G. Volpe, G. Meco, A. Brice, NW. Wood, B. Müller-Myhsok, T. Gasser. European Journal of Human Genetics 2005;13:193-197.

74.   Unrecognized depression in community-dwelling elderly persons in İstanbul. Baral-Kulaksızoğlu, H. Gürvit, A. Polat, H. Harmancı, S. Cakır, HA. Hanağası, B. Bilgic, M. Emre. International Psychogeriatrics 2005;17:303-312.

75.   Obsessive-compulsive disorder secondary to bilateral frontal damage due to a closed head injury. Bilgic, I. Baral-Kulaksızoğlu, HA. Hanağası, M. Şaylan, E. Aykutlu, H. Gürvit, M. Emre. Cognitive and Behavioral Neurology 2004;2:118-120.

76.   Clozapine treatment in oromandibular dystonia. Hanağası, B. Bilgiç, H. Gürvit, M. Emre. Clinical Neuropharmacology 2004;27:84-86.

77.   Risk factors for Alzheimer disease: a population-based case-control study in İstanbul, Turkey. Harmancı, M. Emre, H. Gurvit, B. Bilgic, HA. Hanağası, E. Gurol, H. Sahin, S. Tinaz. Alzheimer Dis Assoc Disord. 2003;17:139-45.

78.   Cognitive impairment in amyotrophic lateral sclerosis: evidence from neuropsychological investigation and event-related potentials. Hanağası, İH Gürvit, N. Ermutlu, G. Kaptanoğlu, S. Karamürsel, HA. İdrisoglu, M. Emre, T. Demiralp. Brain Research-Cognitive Brain Research 2002; 14(2): 234-244.

79.   Therapeutic effects of an acetylcholinesterase inhibitor (donepezil) on memory in Wernicke-Korsakoff’s Disease. Şahin, İH Gürvit, B. Bilgiç, HA Hanağası , M. Emre. Clin Neuropharmacol 2002; 25(1):16-20.

80.   Stiff leg syndrome  – case report. Gürol, M. Ertaş, HA Hanağası, HA Şahin, M. Emre. Movement Disorders-2001; 16(6): 1189-1193.

81.   Do unilateral ablative lesions of the subthalamic nucleus in parkinsonian patients lead to hemiballism? Barlas, HA. Hanağası, M. İmer, HA. Şahin, S. Sencer, M. Emre. Movement Disorders-2001; 16(2): 306-310.

82.   Atypical neurolocigal involvement associated with celiac disease. HA Hanağası,  E. Gürol, HA. Şahin, M Emre. European Journal of Neurology- 2001; 8: 67-69.

83.  Intravenous apomorphine therapy in Parkinson’s disease-clinical and pharmacokinetic observations. Manson, HA Hanağası, K Turner, PN Patsalos, P. Carey, N Ratnaraj, AJ. Lees. Brain-2001; 124: 331-340.

84.   Evidence-based pharmacological treatment of dementia: a review. M.Emre, HA. Hanağası. European Journal of Neurology 2000; 7(3): 247-253.

85.   Neuronal intranuclear inclusion disease and juvenile parkinsonism. O’Sullivan, HA. Hanağası, SE. Daniel, P. Tidswell, SW. Davies, AJ. Lees. Movement Disorders 2000; 15(5): 990-995.

86.    The use of   memantine in drug-resistant dyskinesias due to L-dopa. Hanağası, G. Kaptanoğlu, HA. Şahin, M. Emre. Movement Disorders 2000; 15(5): 1016-1017.

 


ULUSLARARASI BİLDİRİLER


  1.     Video-Oculography Assessment in Neurodegenerative Ataxias and Neimann Pick Type C.  Hanağası, Z. Karaarslan, B. Bilgiç, Z. Tüfekçioglu, A. Demirtas Tatlidede, H. Gürvit, M. Emre. 23th International Congress of Parkinson’s Disease and Movement Disorders. Vancouver-2017. Movement Disorders 2017;32 (Supp 2):787.
  2.     C19orf12 p.Thr11Met mutation is frequent among adult Turkish patients with MPAN. Quadri, S. Olgiati, O. Dogu, Z. Tufekcioglu, Y. Diler, E. Saka, M. Gultekin, H. Kaleagasi, D. Kuipers, J. Graafland, G. Breedveld, R. Sürmeli, G. Sünter, T. Dogan, A.D. Yalçin, B. Bilgiç, B. Elibol, M. Emre, HA. Hanağası,, V. Bonifati. 23th International Congress of Parkinson’s Disease and Movement Disorders. Vancouver-2017. Movement Disorders 2017;32 (Supp 2):441.
  3.     Sporadic fatal insomnia in a young man. Gürvit, B. Bilgiç, A. Özdağ, F. Tepgeç, E. Şahin, Z. Tüfekcioglu, A. Demirtaş-Tatlıdede, HA. Hanağası, D. Karadeniz. Alzheimer’s Association International Conference. konferansı dahilinde “Alzheimer’s and Dementia. 2016; 12 Suppl 1” bildiri kitapçığındaki “”, 496 pp., Toronto, Kanada, Temmuz 2016.
  4.     GRN c. 708+ 1_+4del TGAG deletion in a large family diagnosed with fronto-temporal dementia. Babacan-Yıldız, G. Güven, HA. Hanagasi, B. Bilgiç, H. Gürvit, N. Erginel-Unaltuna, R. Gueirreiro, E. Lohmann. 10th International Conference on Frontotemporal Dementias Conference Journal of Neurochemistry, 2016; 138, bildiri kitapçığındaki “” 323 pp.,  Münih, Almanya, Eylül, 2016.
  5.     A novel homozygous DJ1 mutation causes Parkinsonism and ALS in a Turkish family. Hanagasi, A. Giri, G. Guven, B. Bilgic, A.-K. Hauser, M. Emre, P. Heutink, N. Basak, T. Gasser, J. Simon-Sanchez, E. Lohmann. 22th International Congress of Parkinson’s Disease and Movement Disorders. Berlin-2016. Movement Disorders 2016;31 (Supp 2):206.
  6.     Theta burst repetitive transcranial magnetic stimulation in a case with cortical-basal ganglionic degeneration. Demirtas-Tatlidede, Z. Matur, B. Bilgic, HA. Hanagasi, M. Emre, H Gurvit, E. Oge. 22th International Congress of Parkinson’s Disease and Movement Disorders. Berlin-2016. Movement Disorders 2016;31 (Supp 2):87.
  7.     Face and color recognition after subthalamic nucleus stimulation in Parkinson’s disease. Gündüz, S. Yagci, S. Aydin, BC. Poyraz, G. Genc, S. Oguz, H. Apaydin, G. Kiziltan, HA. Hanagasi, M. Hanci, S. Ertan. 22th International Congress of Parkinson’s Disease and Movement Disorders. Berlin-2016. Movement Disorders 2016;31 (Supp 2):15-16.
  8.     Compromised Regulation of Serum Cytokine Levels and BDNF Due to Low Levels of Vitamin D in Patients with Early or Late Onset Alzheimer’s Disease or Parkinson’s Disease. Gezen Ak, B B. Bilgiç, HA. Hanagasi, S. Ertan, E. Lohmann, E. Dursun, H. Gürvit, S. Yılmazer, I.Atasoy. Alzheimer’s Association International Conference (AAIC 2015) Washington. Alzheimer’s & Dementia  11(7), 649-650.
  9.     Association of Clusterin Polymorphisms and Alzheimer’s Disease. Alaylıoglu, D. Gezen Ak, E. Dursun, HA. Hanagasi, , B. Bilgic, H. Gurvit, S. Yılmazer. Alzheimer’s Association International Conference (AAIC 2015) Washington. Alzheimer’s & Dementia  11(7), 358.
  10.    Anti-NMDA receptor encephalitis with cancer of unknown primary origin. Tuzun, A. Çoban, R. Türkoglu, B. Bilgiç, HA. Hanagasi, H. Gürvit. 1st Congress of the European-Academy-of-Neurology  Berlin, GERMANY EUROPEAN JOURNAL OF NEUROLOGY 22;(Supplement 1):526.
  11.    PSEN1 mutation presenting as posterior cortical atrophy. Gurvit, B. Bilgic, HA. Hanagasi, G. Guven, R. Guerreiro, J. Hardy. World Congress of Neurology Santiago-2015. Journal of the Neurological Sciences, Vol. 357, e127.
  12.    Adult onset  phenylketonuria with rapidly progressive dementia and parkinsonism. Tufekcioglu, A. Cakar, B. Bilgic, HA. Hanagasi, H. Gurvit, M. Emre. 21th International Congress of Parkinson’s Disease and Movement Disorders. San Diego-2015. Movement Disorders 2015;Supp 1:1237.
  13.    Secondary paroxysmal kinesigenic dyskinesia associated with CLCN2 gene mutation. Hanagasi, B. Bilgic, T.E.M. Abbink, Figen Hanagasi, Z. Tüfekçioglu, N. Başak, M.S. van der Knaap, M. Emre. 21th International Congress of Parkinson’s Disease and Movement Disorders. San Diego-2015. Movement Disorders 2015;Supp 1:1165.
  14.    MOCA, MMSE and ACE-R for the assessment of Mild Cognitive Impairment in patients with Parkinson’s Disease. Hanağası, P. Uysal-Cantürk, B. Bilgiç, H. Gürvit, M. Emre. Alzheimer’s Association International Conference Copenhagen 2014, P1-343.
  15.   Evaluation of Incidence and Clinical Features of Antibody-Associated Autoimmune Encephalitis Mimicking Dementia. Erdag, A. Çoban, Cİ. Küçükali, B. Bilgiç, HA. Hanağası, H. Gürvit, E. Tüzün. Alzheimer’s Association International Conference Copenhagen 2014, P1-165.
  16.    Neuroimaging findings of Nasu-Hakola disease. Bilgiç, Ö. Gelişin, R. Guerreiro, E. Lohmann, HA. Hanağası, H. Gürvit, M. Emre. Alzheimer’s Association International Conference Copenhagen 2014, P1-287.
  17.    Testing of diagnostic criteria for mild cognitive impairment in patients with Parkinson’s disease. Hanağası, P. Uysal-Canturk, B. Bilgic, H. Gurvit, M. Emre. 20th International Congress of Parkinson’s Disease and Movement Disorders. Stockholm-2014  Movement Disorders. 2014; 29 (Suppl. 1):934.
  18.    Neuroacanthocytosis: A case report. Yiğiter, MA. Elçi, HA. Hanağası. 20th International Congress of Parkinson’s Disease and Movement Disorders. Stockholm-2014  Movement Disorders. 2014; 29 (Suppl. 1):529.
  19. The distinct genetic pattern of ALS in Turkey. Özoğuz, Ö. Uyan, G. Birdal, C. Iskender, Ö. Ömür, S. Lahut, Z.S. Agim, E. Kartal, Y. Parman, E. Tan, F. Koç, F. Deymeer, P. Oflazer, HA. Hanağası, H. Gürvit, B. Bilgiç, H. Durmuş, M. Ertaş, D. Kotan, M.A. Akalın, H. Güllüoğlu, M. Zarifoğlu, F. Aysal, N. Döşoğlu, K. Bilguvar, M. Günel, Ö. Keskin, T. Akgün, H. Özçelik, A.N. Başak. Joint Congress of European Neurology, Istanbul, 2014. European Journal of Neurology 2014;21 (Suppl. 1):63.
  20.    Botulinum toxin type-A injections for oromandibular dystonia. Tufekcioglu, Z. Matur, HA. Hanağası, Y. Parman. Joint Congress of European Neurology, Istanbul, 2014. European Journal of Neurology 201;21 (Suppl. 1):450.
  21.    Neuropsychological evaulation and cortical thickness analysis of anasognosia in mild cognitive impairment and Alzheimer’s’disease. Senturk, B. Bilgic, C. Kenar, HA. Hanağası, H. Gurvit, M. Emre. International Confrence of Alzheimer Disease Boston, 2013. Alzheimer’s&Dementia 2013;4 (Supp 2):592.
  22.    Association between vitamin D binding protein (VDBP) haplotype and late-onset Alzheimer’s disease. Araz, E. Dursun, D. Gezen-Ak, HA. Hanağası, B. Bilgic¸ E. Lohmann, T. Ertan, Gurvit, E. Eker, M. Emre, S. Yilmazer. International Confrence of Alzheimer Disease Boston, 2013.Alzheimer’s&Dementia 2013;4 (Supp 2):177.
  23.    Serum TNF alpha Levels elevated in early and late onset Alzheimer’s disease but not in mild cogntive impairment. Alaylioglu, D. Gezen-Ak, E. Dursun, HA. Hanağası, B. Bilgic¸ E. Lohmann, OS. Araz, Atasoy, B. Onal, H. Gurvit, S. Yilmazer.
  24. 24.Non-Paraneoplastic limbic encephalitis associated with glutamic acid decarboxylase antibody. Hanağası, B. Bilgic, U. Cikrikcili, C. Ulusoy, S. Turan, B. Baykan, E. Tüzün, M. Emre, Gurvit. International Confrence of Alzheimer Disease Boston, 2013. Alzheimer’s&Dementia 2013;4 (Supp 2):731.
  25.    Homozygous TREM2 Mutations another addition to the list of genetic causes of familial fontotemporal dementia. Gurvit, B. Bilgic, HA. Hanağası, R.Guerreiro, J.Hardy. International Confrence of Alzheimer Disease Boston, 2013. Alzheimer’s&Dementia 2013;4 (Supp 2):860.
  26.    Neural correlates of lack of insight in mild cognitive impairment and Alzheimer’s disease. Bilgic, G. Senturk, HA. Hanağası, H. Gurvit, M. Emre. International Confrence of Alzheimer Disease Boston, 2013. Alzheimer’s&Dementia 2013;4 (Supp 2):587.
  27.    Serum complement factor H levels in late onset Alzheimer’s disease. Yilmazer, D.Gezen-Ak, E. Dursun, HA. Hanağası, B. Bilgic, E. Lohhman, OS.Araz, I. Atasoy, M. Alaylioglu, B. Onal, H. Gurvit. 38th Congress of the Federation-of-European-Biochemical-Societies (FEBS) Saint Petersburg, Russia-2013. FEBS JOURNAL 2013; 280; SI: 430.
  28.   FBXO7 mutation: Phenotypic variability from chorea to early-onset asymmetric parkinsonism within a family. Gunduz, AG. Eken, A. Gundogdu, K. Bilguvar, M. Gunel, AN. Basak, HA. Hanağası. Ertan. 19th International Congress of Parkinson’s Disease and Movement Disorders. Sydney-2013 Movement Disorders   2013; 28   Supplement: 1:  317-318.
  29.    Prevalence of Parkinson’s disease in Baskale, Turkey: A population-based study. Durmus, MA. Gokalp, HA. Hanağası. 19th International Congress of Parkinson’s Disease and Movement Disorders. Sydney-2013 Movement Disorders   2013; 28   Supplement: 1:  384-385.
  30.    Improvement under donepezil treatment in a patient with pure akinesia with freezing of gait. Topcular, A. Yabalak, A. Kaymaz, A. Altinkaya, NS. Topcular, B. Altunrende, E. Altindag, GA. Demir, HA. Hanağası, M. Emre. 19th International Congress of Parkinson’s Disease and Movement Disorders. Sydney-2013 Movement Disorders   2013; 28   Supplement: 1:  297-298.
  31.    MDS-UPDRS dopamine dysregulation syndrome scores correlate with Iowa gambling test performance. Gurvit, N. Pulur, AD. Tatlidede, E. Yildirim,B. Bilgic, R. Cakmur, R  HA. Hanağası. 19th International Congress of Parkinson’s Disease and Movement Disorders. Sydney-2013 Movement Disorders  2013; 28 Supplement: 1:  118.
  32.    Comparative analysis of event-related potentials and oscillations during auditory oddball task in Parkinson’s patients with Parkin gene mutations and idiopathic Parkinson’s disease. Uslu, M. Ergen, H. Demirci, HA. Hanağası, T. Demiralp. XIth International Conference on Cognitive Neuroscience (ICON XI), September 25-29, 2011. Palma, Mallorca, Spain. Abstract booklet: A140.
  33.    The effect of memantine on neuropsychiatric inventory (NPI) parallels with the reduction of caregiver burden: An analysis of an observational study in naturalistic setting. Kulaksızoğlu, H. Gürvit, G. Babacan, HA. Hanağası, H. Şahin, M. Emre. International Confrence of Alzheimer Disease Paris, 2011. Alzheimer’s & Dementia 2011; 7(supl 1):766.
  34.    Frontal white matter hyperintensities correlate with depresive symptoms and functionality in mild Alzheimer’s disease. Bilgic, A. Bayram, H. Alpsan, A. Tumac, HA. Hanağası, H. Şahin, E. Lohmann, M. Emre, H. Gürvit. International Confrence of Alzheimer Disease Paris, 2011. Alzheimer’s & Dementia 2011; 7(supl 1):728.
  35.    The effects of rasagiline on cognitive deficits in Parkinson’s Disease patients without dementia: A randomized, double-blind, placebo-controlled, multi-center study over 3 months.  Hanağası, IH. Gürvit, P. Unsalan, H. Horozoglu, N. Tuncer, A. Feyzioglu, DI. Gunal, R. Cakmur, GG Yener, HA. Sahin, M. Emre. 15th International Congress of Parkinson’s Disease and Movement Disorders. Toronto-2011. Movement Disorders 2011;26 (supl. 2): 280.
  36.    The effects of GRIN gene variations on age at onset of Turkish Huntington’s disease patients. Tunali, A. Acar-Hazer, N Erginel-Unaltuna, HA. Hanağası. EHDN Plenary Meeting Prag-2010. J Neurol Neurosurg Psychiatry 2010;81:A17.
  37.    TP53 R72P polymorphism as a modifier of age at onset of Huntington’s disease. Tunali, A. Acar-Hazer, N. Erginel-Unaltuna, HA. Hanağası. EHDN Plenary Meeting Prag-2010. J Neurol Neurosurg Psychiatry 2010;81:A17.
  38.    Event-related potentials and oscillations during oddball task in Parkinson patients with PARK2 gene mutations. Uslu, T. Demiralp, M. Ergen, H. Demirci, HA. Hanağası. ECNS İstanbul 2010. Abstract booklet: 46.
  39.    An observational study in naturalistic setting on th efficacy of memantine on behavioral symptoms od Alzheimer’s Disease. Gürvit, IB. Kulaksızoğlu, M. Emre, G. Babacan, HA. Hanağası, EDSE Study Group. International Confrence of Alzheimer Disease Hawai, 2010. Alzheimer’s & Dementia 2010; 6(supl 1):310.
  40.     Botulinum toxin injections on the facial region. Matur, A. Çoban, G. Babacan, E. Shugaiv, HA. Hanağası, Y. Parman. Meeting of the European Neuological Society Berlin, 2010. Journal of Neurology 2010; 257(supl 1):230.
  41.    Extrapontine myelinolysis after correction of hyponatremia presenting as acute parkinsonism. Hanağası, D. Aygün, F. Tufan, G. Babacan, H. Gürvit, J. Yazıcı, M. Emre. WFN World Congress on Parkinson’s Disease and Related Disorders Miami, 2009. Parkinsonism&Related Disorders 2009;15(supl 2):107-108.
  42.    Autosomal-recessive gene mutation frequencies in Turkish patients with Parkinson’s disease. Dursun, E. Lohmann, S. Lesage, HA. Hanağası, Ö. Aydın, G. Babacan, H. Gürvit, J. Yazıcı, N. Unaltuna-Erginel, M. Emre, A. Brice. 13th International Congress of Parkinson’s Disease and Movement Disorders. Paris-2009. Movement Disorders 2009;22 (supl. 1): 137-138.
  43.    LRRK2 Exon 41 mutations are not common in Turkey.  Hanağası, E. Lohmann, B. Dursun, A. Honoré, S. Lesage, Ö. Aydın, G. Babacan, H. Gürvit, J. Yazıcı, N. Unaltuna-Erginel, A. Brice, M. Emre. 13th International Congress of Parkinson’s Disease and Movement Disorders. Paris-2009. Movement Disorders 2009;22 (supl. 1): 141.
  44.    Polymorphisms in TNF-alpha (-308), IL-6 (-174) and IL-10 (-1082) genes and the risk for sporadic late-onset Alzheimer’s disease. Vural, S. Degirmencioglu, H. Parıldar-Karpuzoğlu, S. Doğru-Abbasoğlu, HA. Hanağası, B. Karadağ, H.Gürvit, M. Emre, M. Uysal. 3th International Congress of Molecular Medicine İstanbul-2009. IUBMB Life 2009;61:377.
  45.    Anti-neuronal antibodies in Hashimato’s thyroiditis patients with central nervous system involvement. Durmus, S. İçöz, E. Tüzün, M. Kürtüncü, HA. Hanağası, N. Bebek, B. Baykan, G. Akman-Demir, M. Eraksoy. Meeting of the European Neurological Society Nice-2008. J Neurol 2008:255(Suppl 2): 139.
  46.    Polymorphisms in the DNA repair genes, Hogg1 and Ape1 and the risk of Alzheimer’s disease. Parıldar-Karpuzoğlu, S. Doğru-Abbasoğlu, HA. Hanagasi, B. Karadağ, H.Gürvit, M. Emre, M. Uysal. International Congress on Alzheimer’s Disease. Şikago-2008. Alzheimer’s&Dementia 2008:4 (supl. 2): 587.
  47.    Ataxia with vitamin E deficiency in Turkey. Hanagasi, B. Castellotti, C. Mariotti, C. Gellera, H. Gürvit, J. Yazici, M. Emre. 12th International Congress of Parkinson’s Disease and Movement Disorders. Şikago-2008. Movement Disorders 2008;22 (supl. 1): 456.
  48.    Comparison of unilateral pallidotomy versus subthalamotomy in advanced idiopathic Parkinson’s disease. Hanağası, A. Çoban, S. Bilgiç, H. Gürvit, J. Yazıcı, O. Barlas, M. Emre. WFN World Congress on Parkinson’s Disease and Related Disorders. Parkinsonism&Related Disorders 2007;13(supl ):172-173.
  49.    Event-related oscillations in Alzheimer’s disease. Gürvit, HA. Hanağası, Z. Bayraktaroğlu, M.Emre, T. Demiralp. 23th International Conference of Alzheimer’s Disease International.  Caracas-Venezuela. Abstract booklet 2007:53.
  50.    Clinical aspects of L-2-HGA disease in 13 Turkish children. Yapıcı, K. Alpay, D. Yalçın, HA. Hanağası, M. Eraksoy. 17th Meeting of the European Neurological Society. Neurol 2007; 254(Suppl 3):97-98.
  51.    Retrospective cross-over evaluation of two botulinum toxin type A preparations (Botox® and Dysport®) in the treatment of lower limb spasticity. Parman, HA. Hanağası, B. Topcular. 11th International Congress of Parkinson’s Disease and Movement Disorders. İstanbul-2007. Movement Disorders 2007;22 (supl. 16): 279.
  52.    Retrospective cross-over evaluation of two botulinum toxin type A preparations (Botox® and Dysport®) in the treatment of upper limb spasticity. Parman, HA. Hanağası, B. Topcular. 11th International Congress of Parkinson’s Disease and Movement Disorders. İstanbul-2007. Movement Disorders 2007;22 (supl. 16): 277.
  53.    Efficiency of botulinum toxin in treatment of writer’s cramp: Long-term follow-up results. Matur, HA. Hanağası, Y. Parman. 11th International Congress of Parkinson’s Disease and Movement Disorders. İstanbul-2007. Movement Disorders 2007;22 (supl. 16): 41.
  54.    Parkin immunolocalization in target fibers. Yilmazer, H. Tasli, HA. Hanağası, M. Emre, P. Serdaroglu. XIth International Congress on Neuromuscular Diseases İstanbul-2006. Neuromusculer Disorders 2006;16 (supl 1): 79.
  55.    Event-related oscillations in mesial temporal sclerosis and Alzheimer’s disease. Gürvit, Z. Bayraktaroğlu, HA. Hanağası, F. Hanağası, A. Gökyiğit, T. Demiralp. 13th World Congress of Psychophysiology. International Journal of Psychophysiology 2006;61:299-300.
  56.    SNPS at the ligand binding site of the vitamin D receptor gene and Alzheimer’s disease. Gezen-Ak, E. Dursun, T. Ertan, HA. Hanağası, H. Gürvit, M. Emre, E. Eker, M. Ozturk, F. Engin, S. Yılmazer. 10th International Alzheimer’s disease and related disorders. Madrid-2006. Alzheimer’s&Dementia 2006;3 (Suppll. 1): 195-96.
  57.    Neurosyphilis presenting status epilepticus: Two HIV (-) patients with EEG features. C. Gurses, M. Kurtuncu, N. Yesilot, HA. Hanağası, N. Bebek, B. Baykan, M. Emre, A.Gokyigit. 18.World Congress of Neurology, Sydney-2005. Journal of the neurological sciences 2005; 238 (Supll. 1):  124.
  58.    The ERP characteristics of early Alzheimer’s disease. Gürvit, B. Eryaşar, Z. Bayraktaroğlu, B. Bilgiç, HA. Hanağası, M. Emre, T. Demiralp. International Conference on cognitive neuroscience. Havana-2005. Scientifitic Programs & Abstracts Book 2005:312.
  59.    Time-frequency analysis of event-related potentials (ERPS) in mild Alzheimer disease (AD). Bayraktaroğlu, B. Eryaşar, B. Bilgiç, HA. Hanağası, H. Gürvit, M. Emre, T. Demiralp. International Conference on cognitive neuroscience. Havana-2005. Scientifitic Programs & Abstracts Book 2005:316.
  60.    Abundant COX (-) fibers in muscle of a patient with a novel parkin mutaion. H.A Hanağası, P. Serdaroğlu, M. Ozansoy, H. Gurvit, J. Yazici, N. Basak, M. Emre. 14 International Congress on Parkinson Disease. Berlin-2005. Parkinsonism&Related Disorders 2005;11(supl 2):185.
  61.    Validation study of the Turkish Translation of the frontal behavioural inventory (FBI). ŞA. Kalem, HA. Hanağası,  A. Kertesz, H. Gürvit. 21th International Conference of Alzheimer’s Disease International.  Istanbul- Turkey. Abstract booklet 2005:58.
  62.    Validation study of the Turkish Translation of the neuropschiatric inventory (NPI). ŞA. Kalem, HA. Hanağası,  JL. Cummings, H. Gürvit. 21th International Conference of Alzheimer’s Disease International.  Istanbul- Turkey. Abstract booklet 2005:58.
  63.    A novel presenilin 1 mutation (ALA396THR) is associated with early-onset Alzheimer’s disease.  Hanağası, FS. Hocaoğlu, B. Yokeş, H. Gürvit, M. Emre, AN. Başak. 21th International Conference of Alzheimer’s Disease International.  Istanbul- Turkey. Abstract booklet 2005:52.
  64.    Polymorphisms at the ligand binding site of the vitamin D receptor gene and Alzheimer’s disease. Gezen-Ak, E. Dursun, T. Ertan, HA. Hanağası, H. Gürvit, M. Emre, E. Eker, M. Ozturk, F. Engin, S. Yılmazer. 21th International Conference of Alzheimer’s Disease International.  Istanbul- Turkey. Abstract booklet 2005:50.
  65.    Pain in Parkinson’s Disease. Hanagasi, S. Akat, H. Gurvit, M. Emre, J. Yazici. 9h International Congress of Parkinson’s Disease and Movement Disorders. New Orleans-2005. Movement Disorders. 2005;20 (supl. 10):99.
  66.    Target P3b potentials in the novelty paradigm are more sensitive than oddball P3b potentials in detecting cognitive impairment in early stage Alzheimer’s Disease (AD). Eryasar, B. Bilgic, HA. Hanagasi, U. Aydin, M. Emre, T. Demiralp. XIV. The Evoked Potentials International Conference Leipzig-2004. Abstract booklet 2004:67.
  67.    Presenilin-1 gene intronic polymorphism in late-onset Alzheimer’s disease. Dursun, D. Gezen-Ak, E. Eker, T. Ertan, F. Engin, HA. Hanağası, H. Gürvit, M. Emre, S. Yılmazer. 9th  International Alzheimer’s disease and related disorders. Philadelphia-2004. Neurobiology of Aging 2004;25 (Supl.2):511.
  68.    Polymorphisms of the DNA repair gene XRCC1 and Alzheimer’s disease. Dogru-Abbasoğlu, HA. Hanağası, N. Başak, M. Emre. M. Uysal, G. Aykaç-Toker. 29th meeting of the federation of the European biochemical societies. European Journal of Biochemistry 2004;271(Supl.1): 11-12.
  69.    Mitochondrial complex I activity in familial and sporadic Parkinson’s disease. Hanagasi, D. Ayribaş, K. Baysal. M. Emre. 8th International Congress of Parkinson’s Disease and Movement Disorders. Roma-2004. Movement Disorders. 2004;19 (supl. 9):148.
  70.    The prevalance of Alzheimer type dementia in a Turkish urban population. Gurvit, B. Bilgic, HA. Hanagasi, H. Sahin, S. Tınaz, E. Gurol, H. Harmancı, M. Emre. 19th International Conference of Alzheimer’s Disease International.
  71.    The attitude of Turkish elderly towards the symptoms of dementia. Gurvit, H. Sahin, B. Bilgic, E. Gurol, HA. Hanagasi, S. Tınaz, H. Harmancı, M. Emre. 19th International Conference of Alzheimer’s Disease International.
  72.    Clinical and magnetic resonance imaging findings of HIV-negative syphilis patients. B. Bilgic, C. Gurses, B. Topcu, N. Yesilot, M. Kurtuncu, HA. Hanağası, H. Sahin, G. Akman-Demir, H. Gurvit, O. Coban, M. Emre. 13th Meeting of the European Neurological Society. Journal of Neurology 2003;250 (Supl. 2):166.
  73.    Community study of geriatric depression in Turkey: Prevalance and sociodemographic correlates. Kulaksızoğlu, A. Polat, H. Harmancı, HA. Hanağası, B.Bilgic, H. Gürvit, M.Emre. American Association for Geriatric Psychiatry 16th Annual Meeting Honolulu-2003. Abstract booklet 2003:374-375.
  74.    Mitochondrial complex II/III and complex IV activities in familial and sporadic Parkinson’s disease. Hanağası, D. Ayribas, K. Baysal, M. Emre. 7th International Congress of Parkinson’s Disease and Movement Disorders. Miami-2002. Movement Disorders. 2002;17 (supl. 5):150.
  75.     Treatment of writer’s cramp with botulinum toxin. Evaluation of 11 patients.  Hanağası, Y. Parman, HA. Şahin, H. Gürvit, J. Yazıcı, M. Emre. International Conference 2002, Basic and Therapeutic aspects of botulinum and tetanus toxins Hannover-2002. Naunyn-Schmiedeberg’s Archieves of Pharmacology 2002:365 (supp2):23.
  76.    Huntington’s disease in Turkey: The first report on molecular testing. Ersoy, B. Baboğlu, HA. Hanağası, S. Kızkın, AN. Başak. 19th International meeting of the world federation of neurology research group on Huntington’s disease. Abstract booklet 2001:37-38.
  77.    Behavioral and psychological symptoms of Alzheimer’s disease in Turkey. Çakır, H. Gürvit, IB. Kulaksızoğlu, HA. Hanağası, H. Şahin, M. Emre. 10th. Congress of the International Psychogeriatric Association. International Psychogeriatrics 2001;13(Suppl 2):212.
  78.    Unilateral ablative lesions of the subthalamic nucleus in advanced Parkinson’s disease.  Hanağası, O. Barlas, HA. Şahin, M. İmer, M. Emre. International Congress on Parkinson Disease. Helsinki-2001. Parkinsonism&Related Disorders 2001;5(supl):122.
  79.    Clozapine treatment in oromandibular dystonia. Hanağası. 6th International Congress of Parkinson’s Disease and Movement Disorders. Barcelona-2000. Movement Disorders. 2000;15 (supl. 3):138-139.
  80.    Familial Creutzfeldt-Jakob disease in Turkey: Characterization of the Codon 178 Asp-Asn mutation in a large Turkish kindred. Ozansoy, T. Campbell, N. Ersoy, D. Craufurd, A. Dodge, A. Boyacıyan, I. Baral, N. Erbeş, HA. Hanağası, G. Kaptanoğlu, İH. Gürvit, M. Emre, J Collinge, AN. Başak. 31st Annual Meeting of the European Society of Human Genetics Geneva-Switzerland -1999. European Journal of human Genetics 1999:7 (supl 1):124.
  81.    Neuronal intranuclear inclusions in juvenile parkinsonism. O’Sullivan, HA. Hanağası, SE. Daniel, AJ. Lees. 1.International Congress on Parkinson Disease. Vancouver-1999. Parkinsonism&Related Disorders 1999;5(supl):24.
  82.    Stiff Leg Syndrome- A focal form of Stiff Man Syndrome?  Hanağası, E. Gürol, HA. Şahin, M. Emre.1.International Congress on Parkinson Disease. Vancouver-1999. Parkinsonism&Related Disorders 1999;5(supl):122.
  83.    Celiac disease and Neurologic Involvement: A case report. Hanağası, H Şahin, E Gürol, M. Emre. 1.International Congress on Parkinson Disease. Vancouver-1999. Parkinsonism&Related Disorders 1999;5(supl):122.
  84.    Event-related brain potentials  in Amyotrophic Lateral Sclerosis patients. Ermutlu, HA. Hanağası, G. Kaptanoğlu, S. Karamürsel, İH Gürvit, HA. İdrisoğlu, M. Emre, T. Demiralp. 9th World, Congress of the International Organization of Psychophysiology Sicily-1998. International Journal Of Psychology 1998;30(1-2):160-161.
  85.    Motor neuron disease and frontal lobe dementia: A report of three cases. İ. H. Gürvit, E. Tüzün, HA. Hanağası, G. Kaptanoğlu and H. A. İdrisoğlu. XVI World Congress of Neurology Buenos Aires, Argentina, Journal of the Neurological Sciences 1997;150(Supplement1):153.
  86.     Neuropsychological assessment and ERP evaluation of non-demented sporadic ALS patients compared with healthy controls.  Hanağası, İH Gürvit, G. Kaptanoğlu, N. Ermutlu, S. Karamürsel, HA. İdrisoğlu. 8th. International Symposium on  ALS/MND, Abstract Booklet, Glasgow-1997